The global palonosetron hydrochloride market is anticipated to grow at a CAGR of around 5.2% during the forecast period 2020 to 2027 and to reach around US$ 2.9 Bn by 2027.
Market Dynamics
Rapid advancements in drug discovery, high investment for drug development that lower the health effects of chemotherapy or post surgery, and players focus on introduction of innovative solutions are major factors expected to drive the growth of global palonosetron hydrochloride market. In addition, increasing government spending on development of healthcare infrastructure in order to enhance the R&D capabilities and developing medical regulatory scenario are among other factors expected to support the growth of palonosetron hydrochloride market.
Major players are focused on enhancing the business through strategic partnership and innovative product launches is expected to augment the growth of global market.
In 2014, the FDA approved ALOXI® (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
In 2018, Teva Pharmaceutical Industries Ltd. a globally operating pharmaceutical company launched a generic version of ALOXI®1 (palonosetron HCI) injection, 0.25 mg/5 mL, in the United States. The product launch is expected to help the company to enhance the business and strengthen company position in the US market.
In 2018, Helsinn Healthcare SA and Eisai Co., Ltd pharmaceutical companies operating on global level and focused on drug discovery and delivery revised agreement for their chemotherapy-induced nausea and vomiting (CINV) franchise in order to promote and distribute ALOXI® (palonosetron HCl) injection. This agreement is expected to help the company to strengthen its position in the US market.
In 2018, Hikma Pharmaceuticals PLC a company that develops, manufactures, and markets pharmaceutical products across the globe launched Palonosetron Hydrochloride (HCl) Injection, 0.25mg/2mL. This product launch is expected to help the company to enhance the customer base.
In 2018, Dr. Reddy’s Laboratories Ltd. a leading multinational pharmaceutical company launched Palonosetron Hydrochloride Injection, 0.25 mg (base)/ 5 mL, a therapeutic equivalent generic version of ALOXI. This is expected to help the company to enhance the business.
However, factors such as side effects of medicine and strict government regulations related to product approval are expected to hamper the growth of global palonosetron hydrochloride market. In addition, high cost associated to R&D activities is expected to challenge the growth of palonosetron hydrochloride market.
High investment by major players and increasing public-private partnerships for introduction of innovative solutions are factors expected to create new opportunities for players operating in the palonosetron hydrochloride market over the forecast period. In addition, favorable business policies by the government of developing countries and emergence of small & mid-size enterprises with innovative solutions are factors expected to support the revenue transaction of target market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global market due to the increase in the number of cancer patients receiving chemotherapy. In addition, presence of large number of players operating in the country and focus on business expansion through acquisitions this is expected to support the growth of regional market.
Competitive Landscape
The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Report coverage
|
Market
|
Global Palonosetron Hydrochloride Market
|
|
Analysis Period
|
2016 – 2027
|
|
Base Year
|
2019
|
|
Forecast Data
|
2020 – 2027
|
|
Market Stratification
|
Route Of Administration, Distribution Channel and Geography
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
|
Palonosetron Hydrochloride Market Segment Analysis, 2019
The global palonosetron hydrochloride market is segmented into route of administration and distribution channel. The route of administration segment is divided into intravenous and oral. Among the route of administration, the intravenous segment is expected to account for significant revenue share in the target segment. The distribution channel segment is bifurcated into hospital pharmacies, online stores, drug stores, and retail stores.
The players profiled in the report are Merck, Wavelength, Farmihispania Group, ALP Pharm, Shanghai Jinhe Bio-Pharmaceutical Co. Ltd., Tecoland, Qilu Pharmaceutical, Teva API, Novartis, and Roche.
Market Segmentation
Market By Route Of Administration
Intravenous
Oral
Market By Distribution Channel
Hospital Pharmacies
Online Stores
Drug Stores
Retail Stores
Market By Region
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Palonosetron Hydrochloride
1.1. Definition and Scope
1.1.1. Definition of Palonosetron Hydrochloride
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Palonosetron Hydrochloride Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Palonosetron Hydrochloride Market By Route of Administration
1.2.3. Palonosetron Hydrochloride Market By Distribution Channel
1.2.4. Palonosetron Hydrochloride Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Palonosetron Hydrochloride Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Palonosetron Hydrochloride Market
3.7. Value Chain Analysis
3.8. Cost Structure Analysis
3.8.1. Proportion of Manufacturing Cost Structure
3.8.1.1. Raw Material
3.8.1.2. Labor Cost
3.8.1.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Palonosetron Hydrochloride Major Manufacturers in 2019
CHAPTER 5. Palonosetron Hydrochloride Market By Route of Administration
5.1. Introduction
5.2. Palonosetron Hydrochloride Revenue By Route of Administration
5.2.1. Palonosetron Hydrochloride Revenue (US$ Mn) and Forecast, By Route of Administration, 2016-2027
5.2.2. Intravenous
5.2.2.1. Intravenous Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Oral
5.2.3.1. Oral Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Palonosetron Hydrochloride Market Revenue By Distribution Channel
6.1. Introduction
6.2. Palonosetron Hydrochloride Revenue (US$ Mn) By Distribution Channel
6.2.1. Palonosetron Hydrochloride Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
6.2.2. Hospital Pharmacies
6.2.2.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Online Stores
6.2.3.1. Online Stores Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Drug Stores
6.2.4.1. Drug Stores Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Retail Stores
6.2.5.1. Retail Stores Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Palonosetron Hydrochloride Market By Country
7.1. North America Palonosetron Hydrochloride Overview
7.2. U.S.
7.2.1. U.S. Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
7.2.2. U.S. Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.3. Canada
7.3.1. Canada Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
7.3.2. Canada Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Palonosetron Hydrochloride Market By Country
8.1. Europe Palonosetron Hydrochloride Market Overview
8.2. U.K.
8.2.1. U.K. Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.2.2. U.K. Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Germany
8.3.1. Germany Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.3.2. Germany Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. France
8.4.1. France Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.4.2. France Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.5. Spain
8.5.1. Spain Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.5.2. Spain Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.6.2. Rest of Europe Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Palonosetron Hydrochloride Market By Country
9.1. Asia Pacific Palonosetron Hydrochloride Market Overview
9.2. China
9.2.1. China Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
9.2.2. China Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.3. Japan
9.3.1. Japan Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
9.3.2. Japan Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.4. India
9.4.1. India Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
9.4.2. India Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.5. Australia
9.5.1. Australia Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
9.5.2. Australia Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
9.6.2. South Korea Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
9.7.2. Rest of Asia-Pacific Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Palonosetron Hydrochloride Market By Country
10.1. Latin America Palonosetron Hydrochloride Market Overview
10.2. Brazil
10.2.1. Brazil Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.2.2. Brazil Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.3.2. Mexico Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
CHAPTER 11. Middle East & Africa Palonosetron Hydrochloride Market By Country
11.1. Middle East & Africa Palonosetron Hydrochloride Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.2.2. Saudi Arabia Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3. UAE
11.3.1. UAE Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.3.2. UAE Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.4.2. Rest of Middle East & Africa Palonosetron Hydrochloride Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
CHAPTER 12. Player Analysis Of Palonosetron Hydrochloride
12.1. Palonosetron Hydrochloride Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Palonosetron Hydrochloride Market
CHAPTER 13. Company Profile
13.1. Merck
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Merck 2019 Palonosetron Hydrochloride Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Wavelength
13.3. Farmihispania Group
13.4. ALP Pharm
13.5. Shanghai Jinhe Bio-Pharmaceutical Co. Ltd.
13.6. Tecoland
13.7. Qilu Pharmaceutical
13.8. Teva API
13.9. Novartis
13.10. Roche
13.11. Others
